Sartorius Acquires New Lab and Bioprocess Businesses

Sartorius successfully closed the acquisition of leading life science businesses from the Danaher Group. All portfolios represent an excellent fit, adding best-in-class technology for simplifying drug discovery and advancing bioprocessing to Sartorius’ already strong offering. The teams involved look forward to combining capabilities and serving their biopharma and life science customers together.